首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >Antidiabetic and antihyperlipidemic effects of ethanolic Ferula assa-foetida oleo-gum-resin extract in streptozotocin-induced diabetic wistar rats
【24h】

Antidiabetic and antihyperlipidemic effects of ethanolic Ferula assa-foetida oleo-gum-resin extract in streptozotocin-induced diabetic wistar rats

机译:乙醇诱导糖尿病Wistar大鼠中乙醇FERULA ASS-FOETIDA Oleo-Gum树脂提取物的抗糖尿病和抗高血散作用

获取原文
获取原文并翻译 | 示例
           

摘要

The present study was conducted to investigate the hypoglycemic and hypolipidemic activity of ethanolic ferula assa-foetida oleo-gum-resin extract (FAOGRETE) and also its effects on liver and kidney function in streptozotocin (STZ)-induced diabetic rats. For this purpose, 42 male Wistar rats were divided into six groups (n = 7). Diabetes was induced in four groups by a single-dose of STZ at 55 mg/kg body weight, administrated intraperitoneal. After 42 days of treatment, fasting blood sugar (FBS) levels, serum insulin, biochemical parameters such as total cholesterol, triglycerides, low and high density lipoprotein cholesterol were measured. In addition the markers of liver and kidney function, such as glutamic oxaloacetic transaminase, glutamic pyruvic transaminase, alkaline phosphatase, serum creatinine and urea levels were determined. The study showed that the ethanolic extract at 150 mg/kg body weight (b.w) had a significant antidiabetic activity after 42 days of treatment as the FBS levels decreased significantly while the serum insulin levels increased. Moreover, a significant decrease in the liver and kidney function markers in treated rats indicated the protective effect of the ethanolic extract against liver and kidney damage, while body weight increased. The serum concentrations were normal in normal control and healthy group treated with FAOGRETE.
机译:进行了本研究以研究乙醇梭菌ASSA-FOETIDA油脂提取物(FAOGRETE)的低血糖和低血散活性,以及​​其对链脲佐菌素(STZ)诱导的糖尿病大鼠肝肾功能的影响。为此目的,将42只雄性Wistar大鼠分成六组(n = 7)。通过单剂量的STZ在55mg / kg体重,腹膜内诱导糖尿病。在治疗42天后,测量空腹血糖(FBS)水平,血清胰岛素,生化参数,如总胆固醇,甘油三酯,低密度脂蛋白胆固醇。此外,确定了肝肾功能的标志物,例如谷氨酸草酸氨基分甲酰胺酶,谷氨酸丙烷转氨酶,碱性磷酸酶,血清肌酐和尿素水平。该研究表明,150mg / kg体重(B.W)的乙醇提取物在治疗42天后具有显着的抗糖尿病活性,因为FBS水平显着下降,而血清胰岛素水平增加。此外,处理大鼠肝脏和肾功能标记的显着降低表明乙醇提取物对肝脏和肾脏损伤的保护作用,而体重增加。用Faogrete治疗的正常对照组血清浓度正常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号